MSB 2.17% $1.13 mesoblast limited

Heart Failure, page-3

  1. 3,053 Posts.
    lightbulb Created with Sketch. 2
    Let's assume that it is approved on the fast track, despite the fast track requiring some form of efficacy signal from surrogates or interims.

    Why would any ethically sound doctor prescribe something that shows no efficacy? Why would an insurance company reimburse for it?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.